BEYOND AIR INC (XAIR) Stock Price, Quote, News and Overview
NASDAQ:XAIR - Nasdaq - US08862L1035 - Common Stock - Currency: USD
XAIR Quote, Performance and Key Statistics
BEYOND AIR INC
NASDAQ:XAIR (2/4/2025, 8:16:38 PM)
Premarket: 0.3922 +0 (+0.56%)0.39
+0.03 (+8.33%)
The current stock price of XAIR is 0.39 USD. In the past month the price increased by 8.33%. In the past year, price decreased by -79.14%.
XAIR Latest News, Press Releases and Analysis
What's going on in today's after hours session
Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.
Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast
GARDEN CITY, N.Y., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device...
Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia
GARDEN CITY, N.Y., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device...
Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy
The Phase 1b study will evaluate LV UNO in unresectable cutaneous or subcutaneous histologically confirmed primary or metastatic solid tumor cancer...
Beyond Air Receives CE Mark in Europe for the LungFit® PH System
Indication covers newborn infants with hypoxic respiratory failure and peri- and post-operative pulmonary hypertension to improve right ventricular...
XAIR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.64 | 223.92B | ||
| ISRG | INTUITIVE SURGICAL INC | 79.08 | 206.46B | ||
| BSX | BOSTON SCIENTIFIC CORP | 43.87 | 152.60B | ||
| SYK | STRYKER CORP | 32.19 | 149.59B | ||
| MDT | MEDTRONIC PLC | 17.33 | 116.65B | ||
| BDX | BECTON DICKINSON AND CO | 18.42 | 70.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.72 | 42.07B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.6 | 39.72B | ||
| IDXX | IDEXX LABORATORIES INC | 41.34 | 38.08B | ||
| RMD | RESMED INC | 27.2 | 35.30B | ||
| DXCM | DEXCOM INC | 51.45 | 34.16B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 20.23 | 25.29B |
Related stock screener links
About XAIR
Company Profile
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in developing a platform for nitric oxide generators and delivery systems. The company is headquartered in Garden City, New York and currently employs 107 full-time employees. The company went IPO on 2019-05-07. The firm has received United States Food and Drug Administration (FDA) approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19), and nontuberculous mycobacteria (NTM) among others. The company has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder (ASD) and other neurological disorders. Its approved product and active pipeline of product candidates include LungFit PH, LungFit PRO and LungFit GO.
Company Info
BEYOND AIR INC
900 Stewart Avenue, Suite 301
Garden City NEW YORK 11530 US
CEO: Steven Lisi
Employees: 107
Company Website: https://www.beyondair.net/
Investor Relations: http://www.beyondair.net/investors
Phone: 15166658200
XAIR FAQ
What is the stock price of XAIR?
The current stock price of XAIR is 0.39 USD.
What is the symbol for BEYOND AIR INC stock?
The exchange symbol of BEYOND AIR INC is XAIR and it is listed on the Nasdaq exchange.
On which exchange is XAIR stock listed?
XAIR stock is listed on the Nasdaq exchange.
Is XAIR a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for XAIR, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of XAIR.
Does XAIR stock pay dividends?
XAIR does not pay a dividend.
When does XAIR stock report earnings?
XAIR will report earnings on 2025-02-10, after the market close.
What is the Price/Earnings (PE) ratio of XAIR?
XAIR does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.41).
What is the Short Interest ratio of XAIR stock?
The outstanding short interest for XAIR is 1.67% of its float.
XAIR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to XAIR. When comparing the yearly performance of all stocks, XAIR is a bad performer in the overall market: 95.5% of all stocks are doing better.
XAIR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to XAIR. XAIR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
XAIR Financial Highlights
Over the last trailing twelve months XAIR reported a non-GAAP Earnings per Share(EPS) of -1.41. The EPS increased by 31.55% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -104.67% | ||
| ROE | -197.27% | ||
| Debt/Equity | 0.39 |
XAIR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to XAIR. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 56.62% and a revenue growth 161.35% for XAIR